SEMA4D/CD100 抗体
(Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4D (SEMA4D))
Cell surface receptor for PLXN1B and PLXNB2 that plays an important role in cell-cell signaling. Promotes reorganization of the actin cytoskeleton and plays a role in axonal growth cone guidance in the developing central nervous system. Regulates dendrite and axon branching and morphogenesis. Promotes the migration of cerebellar granule cells and of endothelial cells. Plays a role in the immune system\; induces B-cells to aggregate and improves their viability (in vitro). Promotes signaling via SRC and PTK2B/PYK2, which then mediates activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Interaction with PLXNB1 mediates activation of RHOA (By similarity).
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SEMA4D/CD100 抗体 (AA 756-862) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| SEMA4D/CD100 抗体 (AA 756-862) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| SEMA4D/CD100 抗体 (AA 756-862) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| SEMA4D/CD100 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant SEMA4D/CD100 抗体 | 人 | Human Monoclonal |
|
|
|
| SEMA4D/CD100 抗体 (AA 800-850) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant SEMA4D/CD100 抗体 | 人 | Human Monoclonal |
|
|
|
| SEMA4D/CD100 抗体 (AA 755-862) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant SEMA4D/CD100 抗体 | 人 | Human, 兔 Chimeric |
|
|
|
| Recombinant SEMA4D/CD100 抗体 (Biotin) | 人 | Human, 兔 Chimeric |
|
|
|
| SEMA4D/CD100 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| SEMA4D/CD100 抗体 (Extracellular Domain) (PE) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant SEMA4D/CD100 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Recombinant SEMA4D/CD100 抗体 | 人, 小鼠 | 兔 Chimeric |
|
|
|
| Recombinant SEMA4D/CD100 抗体 | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| Recombinant SEMA4D/CD100 抗体 | 人, 小鼠 | 兔 Chimeric |
|
|
|
| SEMA4D/CD100 抗体 (Extracellular, N-Term) (FITC) | 小鼠 | 兔 Polyclonal |
|
|
|
| SEMA4D/CD100 抗体 | 人 | 兔 Monoclonal |
|
|
|
| SEMA4D/CD100 抗体 | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| SEMA4D/CD100 抗体 (N-Term) | 人, 小鼠, 大鼠, 豚鼠, 兔, 马, Cow, 犬 | 兔 Polyclonal |
|
|
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 756-862
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 756-862
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 756-862
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 133-1C6
- 标记
- unconjugated
- 抗体亚型
- IgM
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- 5D12
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG4 S228P
Primary Antibody
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 800-850
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- 21E8
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG4 S228P
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 5H9
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 755-862
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- Human, 兔
- 克隆形成能力
- Chimeric
- 克隆
- 11G2
- 标记
- unconjugated
- Fragment
- Fc fragment
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- Human, 兔
- 克隆形成能力
- Chimeric
- 克隆
- 11G2
- 标记
- Biotin
- Fragment
- Fc fragment
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 133-1C6
- 标记
- unconjugated
- 抗体亚型
- IgM
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1D4B
- 标记
- PE
- 抗体亚型
- IgG1
- 抗原表位
- Extracellular Domain
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- LCI (Live Cell Imaging: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Chimeric
- 克隆
- 133-1G6
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 133-1G6
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgM
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Chimeric
- 克隆
- 133-1G6
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 80-93, Extracellular, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 28S26
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- SDS (SDS-PAGE: 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- Func (Functional Studies: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- A8
- 标记
- unconjugated
- 抗体亚型
- IgG1, kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, 豚鼠, 兔, 马, Cow, 犬
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Latest Publications for our SEMA4D/CD100 抗体
: "Sema4D/PlexinB1 inhibition ameliorates blood-brain barrier damage and improves outcome after stroke in rats." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 32, Issue 4, pp. 2181-2196, (2018) (PubMed).
: "Interferon-α-induced CD100 on naïve CD8+ T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction." in: The Journal of international medical research, Vol. 45, Issue 1, pp. 89-100, (2017) (PubMed).
: "CD100 up-regulation induced by interferon-α on B cells is related to hepatitis C virus infection." in: PLoS ONE, Vol. 9, Issue 12, pp. e113338, (2014) (PubMed).
: "Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells." in: PLoS ONE, Vol. 8, Issue 9, pp. e75772, (2013) (PubMed).
: "CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72." in: PLoS ONE, Vol. 2, Issue 9, pp. e818, (2007) (PubMed).
: "Caspases disrupt the nuclear-cytoplasmic barrier." in: The Journal of cell biology, Vol. 151, Issue 5, pp. 951-9, (2000) (PubMed).
: "Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, Issue 21, pp. 11780-5, (1996) (PubMed).
: "Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line." in: Molecular and cellular biology, Vol. 10, Issue 4, pp. 1793-8, (1990) (PubMed).
: "Interferon-α-induced CD100 on naïve CD8+ T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction." in: The Journal of international medical research, Vol. 45, Issue 1, pp. 89-100, (2017) (PubMed).
: "CD100 up-regulation induced by interferon-α on B cells is related to hepatitis C virus infection." in: PLoS ONE, Vol. 9, Issue 12, pp. e113338, (2014) (PubMed).
: "Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells." in: PLoS ONE, Vol. 8, Issue 9, pp. e75772, (2013) (PubMed).
: "CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72." in: PLoS ONE, Vol. 2, Issue 9, pp. e818, (2007) (PubMed).
: "Caspases disrupt the nuclear-cytoplasmic barrier." in: The Journal of cell biology, Vol. 151, Issue 5, pp. 951-9, (2000) (PubMed).
: "Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, Issue 21, pp. 11780-5, (1996) (PubMed).
: "Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line." in: Molecular and cellular biology, Vol. 10, Issue 4, pp. 1793-8, (1990) (PubMed).
Aliases for SEMA4D/CD100 抗体
semaphorin 4D (Sema4d) 抗体semaphorin 4D (SEMA4D) 抗体
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D (Sema4d) 抗体
C9orf164 抗体
CD100 抗体
coll-4 抗体
COLL-4 抗体
M-sema-G 抗体
Semacl2 抗体
SEMAJ 抗体
Semaj 抗体
Semcl2 抗体
您还需要查找其他产品吗？
- SEMA4C 抗体
- SEMA4B 抗体
- Sema4a 抗体
- SEMA3G 抗体
- SEMA3F 抗体
- SEMA3E 抗体
- SEMA3D 抗体
- SEMA3C 抗体
- SEMA3B 抗体
- Sema Domain, Immunoglobulin Domain (Ig), Short Basic Domain, Secreted, (Semaphorin) 3A 抗体
- SELT 抗体
- SELPLG 抗体
- SELM 抗体
- Selenoprotein W 抗体
- Selenoprotein S 抗体
- Selenoprotein P 抗体
- Selenoprotein K 抗体
- SELENBP1 抗体
- Selectin E/CD62e 抗体
- Seladin 1 抗体
You are here:
